Cognition Therapeutics Publishes Clinical Evidence that
- First Human Evidence that CT1812 Selectively Engages Aβ Oligomers...
Daniel Kontoh Boateng Anthonyo Caggiano Mary Hamby Tiberend Strategic Advisors Inc Securities Exchange Commission Cognition Therapeutics Inc
Source: globenewswire.com